sildenafil citrate effect on IUGR

sildenafil citrate effect on placental blood flow

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201501000895269

Enrollment

Registered

2014-09-29

Start date

2013-12-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth IUGR

Interventions

sildenafil citrate

placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: pregnant in IUGR over 28 weeks gestation any age any parity any medical disorder

Exclusion criteria

Exclusion criteria: congenital anomalies chromosomal anomalies

Design outcomes

Primary

Measure	Time frame
improve placental blood flow	—

Countries

Egypt

Contacts

Public Contactsaid saleh

lecturer menoufia university

dr.said27@yahoo.com00201005245483

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026